| Inflammatory Bowel Disease |
1 |
1 |
| Colitis |
0 |
0.91 |
| Crohn Disease |
0 |
0.83 |
| Ulcerative Colitis |
0 |
0.69 |
| Anti-Tumor Necrosis Factor (Anti-TNF) |
0 |
0.99 |
| Biologic Therapy |
0 |
0.3 |
| Adverse Effects |
0 |
0.14 |
| Clinical Research |
0 |
0.14 |
| Grant |
0 |
0.14 |
| Meta-Analysis |
0 |
0.14 |
| Tumor |
0 |
0.14 |
| Patient Safety |
0 |
0.12 |
| Board Certification |
0 |
0.09 |
| Hospital |
0 |
0.09 |
| Monoclonal Antibody |
0 |
0.09 |
| Healthcare and Medical Technology |
0 |
0.07 |